Your browser doesn't support javascript.
loading
Efficacy and Safety of Garadacimab in Combination with Standard of Care Treatment in Patients with Severe COVID-19.
Papi, Alberto; Stapleton, Renee D; Shore, Paul M; Bica, Mihai Alexandru; Chen, Younan; Larbig, Michael; Welte, Tobias.
Affiliation
  • Papi A; Respiratory Department, University of Ferrara, 44100, Ferrara, Italy. Alberto.papi@unife.it.
  • Stapleton RD; Pulmonary and Critical Care Medicine, University of Vermont, Burlington, VT, USA.
  • Shore PM; Clinical Development, CSL Behring, King of Prussia, USA.
  • Bica MA; Global Clinical Safety and Pharmacovigilance, CSL Behring Innovation, Marburg, Germany.
  • Chen Y; Biostatistics, CSL Behring, King of Prussia, USA.
  • Larbig M; Clinical Development, CSL Behring AG, Bern, Switzerland.
  • Welte T; Department of Pulmonary and Infectious Diseases, Hannover Medical School, Hannover, Germany.
Lung ; 201(2): 159-170, 2023 04.
Article in En | MEDLINE | ID: mdl-37000214

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: Lung Year: 2023 Document type: Article Affiliation country: Italy Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: Lung Year: 2023 Document type: Article Affiliation country: Italy Country of publication: United States